NCT01456286View on ClinicalTrials.gov

Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Liver CirrhosisPortal Hypertension
Interventions
DRUG

sapropterin

two weeks of treatment: 5 mg/kg per day during first week 10 mg/kg per day during second week

Trial Locations (2)

28034

Hospital Ramón y Cajal, Madrid

08036

Hospital Clínic de Barcelona, Barcelona

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT01456286 - Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension | Biotech Hunter | Biotech Hunter